Fort Washington Investment Advisors Inc. OH Raises Stock Position in Option Care Health, Inc. (NASDAQ:OPCH)

Fort Washington Investment Advisors Inc. OH boosted its stake in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 6.2% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 943,300 shares of the company’s stock after purchasing an additional 54,830 shares during the period. Fort Washington Investment Advisors Inc. OH owned approximately 0.55% of Option Care Health worth $21,885,000 at the end of the most recent quarter.

A number of other institutional investors have also modified their holdings of OPCH. Westfield Capital Management Co. LP boosted its position in Option Care Health by 10.2% in the 3rd quarter. Westfield Capital Management Co. LP now owns 6,492,152 shares of the company’s stock worth $203,204,000 after purchasing an additional 599,589 shares in the last quarter. Global Alpha Capital Management Ltd. grew its position in shares of Option Care Health by 108.3% during the 3rd quarter. Global Alpha Capital Management Ltd. now owns 49,818 shares of the company’s stock valued at $1,559,000 after acquiring an additional 25,905 shares during the period. Graypoint LLC purchased a new position in shares of Option Care Health in the 4th quarter valued at about $1,161,000. Victory Capital Management Inc. raised its holdings in Option Care Health by 4,432.8% in the 3rd quarter. Victory Capital Management Inc. now owns 1,621,593 shares of the company’s stock worth $50,756,000 after purchasing an additional 1,585,818 shares during the period. Finally, Barclays PLC boosted its position in Option Care Health by 180.1% during the third quarter. Barclays PLC now owns 310,194 shares of the company’s stock worth $9,708,000 after purchasing an additional 199,454 shares in the last quarter. Hedge funds and other institutional investors own 98.05% of the company’s stock.

Option Care Health Stock Down 0.5 %

OPCH stock opened at $29.31 on Thursday. The firm’s 50 day moving average price is $23.96 and its 200-day moving average price is $27.77. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. The firm has a market cap of $4.99 billion, a PE ratio of 24.63, a PEG ratio of 2.09 and a beta of 1.31. Option Care Health, Inc. has a one year low of $21.39 and a one year high of $34.63.

Insider Activity

In related news, Director Harry M. Jansen Kraemer, Jr. acquired 43,000 shares of the firm’s stock in a transaction dated Friday, November 8th. The shares were purchased at an average cost of $22.54 per share, for a total transaction of $969,220.00. Following the acquisition, the director now owns 326,334 shares in the company, valued at $7,355,568.36. The trade was a 15.18 % increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 0.64% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts recently commented on OPCH shares. UBS Group began coverage on shares of Option Care Health in a report on Thursday, December 5th. They issued a “neutral” rating and a $26.00 price target for the company. Truist Financial reduced their target price on Option Care Health from $41.00 to $34.00 and set a “buy” rating for the company in a report on Friday, November 1st. Barrington Research lifted their price target on Option Care Health from $32.00 to $33.00 and gave the stock an “outperform” rating in a research note on Tuesday, January 14th. Bank of America upgraded shares of Option Care Health from a “neutral” rating to a “buy” rating and increased their target price for the company from $26.00 to $33.00 in a research report on Monday, January 13th. Finally, JMP Securities restated a “market outperform” rating and set a $30.00 price target (down from $31.00) on shares of Option Care Health in a research report on Friday, January 10th. Three equities research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $29.86.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.